Fig. 2From: Long-term effectiveness and safety of lacosamide as adjunctive therapy in children and adolescents with refractory epilepsy: a real-world studyEffectiveness outcome on lacosamide treatment for refractory epilepsy (the total number of people in each group was 105, 97, and 82 patients; the number of responder to lacosamide in each group was 50, 38, and 23 patients; the number of seizure-free to lacosamide in each group was 34, 28, and 17 patients)Back to article page